Nanoengineering Systems for Gene Therapy: Mechanisms, Modalities, and Future Directions

Area of Science:

• Biotechnology
• Materials Science
• Genetics

Background:

• Gene therapy and genome editing face challenges like inefficient delivery and off-target effects.
• Nanotechnology offers novel delivery strategies to improve precision, efficiency, and safety of genetic modifications.

Purpose of the Study:

• To review the role of nanomaterials in overcoming barriers in gene therapy and genome editing.
• To highlight the synergy between nanomaterials and genome engineering tools like CRISPR-Cas systems.
• To discuss next-generation editing technologies and their delivery challenges.

Main Methods:

• Review of current literature on nanotechnology applications in gene therapy and genome editing.
• Emphasis on the integration of nanomaterials with CRISPR-Cas and other advanced editing systems.
• Analysis of therapeutic potential and delivery challenges of various genome engineering modalities.

Main Results:

• Nanomaterials improve the stability, intracellular delivery, and specificity of genome-editing systems.
• Combined use of nanomaterials with CRISPR-Cas enhances editing efficacy and safety.
• Nanocarriers offer controlled release, protection from degradation, and improved biocompatibility.

Conclusions:

• Nanotechnology is crucial for advancing gene therapy and genome editing, enabling effective treatments for genetic and acquired diseases.
• Continued convergence of nanotechnology and genome engineering paves the way for personalized medicine.
• Translational challenges such as immunotoxicity and manufacturing require further attention.